AnaptysBio, Inc. (ANAB)
63.15
+0.96
(+1.54%)
USD |
NASDAQ |
May 15, 16:00
63.22
+0.07
(+0.11%)
After-Hours: 20:00
AnaptysBio Market Cap : 1.838B for May 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vanda Pharmaceuticals, Inc. | 377.65M |
| TG Therapeutics, Inc. | 6.050B |
| ADMA Biologics, Inc. | 1.917B |
| Mirum Pharmaceuticals, Inc. | 6.231B |
| Rocket Pharmaceuticals, Inc. | 354.88M |
Market Cap Related Metrics
| PS Ratio | 8.007 |
| Price to Book Value | 144.17 |
| Price to Free Cash Flow | 422.03 |
| Price | 63.15 |
| Earnings Yield | -1.71% |
| Operating PE Ratio | 45.61 |